The beneficiary BS BIOTECHNA SP. Z O. O. is implementing a project entitled:
‘BS2020 – RESEARCH AND DEVELOPMENT OF A NEW MEDICINAL PRODUCT USED IN THE TREATMENT OF CANCER’
under the Smart Growth Operational Programme for 2014–2020, Sub-measure 1.1.1
PROJECT OBJECTIVE:
To develop an innovative drug for use in molecularly targeted cancer therapy and to confirm its efficacy in breast cancer.
PROJECT VALUE:
PLN 41,901,795.00
EUROPEAN FUNDS CONTRIBUTION:
PLN 32,080,426.80
IMPLEMENTATION PERIOD:
1 April 2021 – 30 November 2023